Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN

Sing George L sold 21,129 Regeneron Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 4, 2026

On Nov 2, 2026, Sing George L (Director) sold 21,129 Regeneron Pharmaceuticals, Inc. shares at an average US$964.38 for US$20.4M, leaving 25,147 shares. Filed Nov 4, 2026 (Form 4).

Sold
21,129 shares
Price
US$964.38 average (US$960.57 to US$970.18)
Value
US$20.4M
Holding after
25,147 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockOption exercise7,830US$376.6938,837Direct
Nov 2, 2026Common StockOption exercise7,439US$380.9546,276Direct
Nov 2, 2026Common StockSale1,224US$960.5745,052Direct
Nov 2, 2026Common StockSale540US$961.8544,512Direct
Nov 2, 2026Common StockSale2,522US$962.6141,990Direct
Nov 2, 2026Common StockSale4,338US$963.4737,652Direct
Nov 2, 2026Common StockSale2,670US$964.5734,982Direct
Nov 2, 2026Common StockSale7,073US$965.3827,909Direct
Nov 2, 2026Common StockSale1,522US$966.2726,387Direct
Nov 2, 2026Common StockSale1,040US$967.0725,347Direct
Nov 2, 2026Common StockSale200US$970.1825,147Direct

Source

Download original · View original at SEC

Related